by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
by Angela C. H. McDonald | Jan 26, 2012
As has been reported broadly this week, transplantation of human embryonic stem cell-derived retinal pigment epithelial cells appears to be safe in human patients, and it may even be efficacious (although this can only be confirmed via a Phase II trial). Advanced Cell...
by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
by David Kent | Jan 6, 2012
Yesterday, a landmark paper emerged from Cell which reported two major findings to the scientific community: Primate embryonic stem cells cannot generate chimeras, and Aggregation and injection of multiple early-stage four-cell primate embryos (not embryonic stem...
by Lisa Willemse | Dec 21, 2011
In a traditional view of medical research, advances tend to be measured against the overarching goal of cure. Noble as this might be, research is rarely such a black and white affair — if we have learned anything, it’s that there are innumerable shades of grey....
by Stem Cell Network | Dec 14, 2011
When we report on breakthroughs in stem cell research, we typically link to well-funded studies published in peer-reviewed journals by world-renowned scientists. This time, it’s a little different. Angela Zhang, a high school senior from Cupertino, California, was...
Comments